Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
183 hedge funds and large institutions have $1.86B invested in Dynavax Technologies in 2021 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 21 closing their positions.
143% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 21
110% more capital invested
Capital invested by funds: $884M → $1.86B (+$974M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
82% more call options, than puts
Call options by funds: $66.6M | Put options by funds: $36.7M
19% more funds holding
Funds holding: 154 → 183 (+29)
6.08% more ownership
Funds ownership: 78.38% → 84.46% (+6.1%)
2% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$68M |
| 2 |
Two Sigma Advisers
New York
|
+$20.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$14.5M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$14.1M |
| 5 |
D.E. Shaw & Co
New York
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$44.6M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$33.5M |
| 3 |
State Street
Boston,
Massachusetts
|
-$23.9M |
| 4 |
Goldman Sachs
New York
|
-$9.32M |
| 5 |
BlackRock
New York
|
-$4.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PHK
201
Point72 Hong Kong
Hong Kong
| – | -$5K | -492 | Closed |
|
|
SOW
202
State of Wyoming
Cheyenne,
Wyoming
| – | -$3K | -270 | Closed |
|
203
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$2K | -250 | Closed |
|
|
S
204
SignatureFD
Atlanta,
Georgia
| – | -$1K | -83 | Closed |
|
DVAX Hedge Fund Activity: Q3 2021 in Review
183 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2021, worth a combined $1.86B — up 110% from $884M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new DVAX positions and 21 closed out — a net gain of 30 holders — while 52 added to existing stakes and 51 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $68M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $44.6M.
- 183 institutional investors held Dynavax Technologies (DVAX) as of Q3 2021, up from 154 in Q2 2021.
- Funds reported $1.86B of Dynavax Technologies stock for Q3 2021, up 110% quarter-over-quarter.
- 51 funds opened new Dynavax Technologies positions in Q3 2021 and 21 closed out, a net change of +30 holders.
- The largest Dynavax Technologies buyer in Q3 2021 was Marshall Wace, an estimated $68M added.
- The largest Dynavax Technologies seller in Q3 2021 was Bain Capital Life Sciences Investors, an estimated $44.6M sold.
Based on aggregated 13F filings for Q3 2021.